Latest Market News

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 amid promising regulatory and market developments.

EDU Holdings reports a modest 2% increase in total student enrolments for its Australian Learning Group in Term 3, 2025, while new student enrolments have sharply declined amid ongoing regulatory challenges.

Biome Australia Limited has delivered record sales revenue in Q4 FY25 alongside positive EBITDA, setting the stage for its first full-year net profit. Strategic product launches and international expansion underpin its strong growth trajectory.

LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.

Algorae Pharmaceuticals has advanced its AI-driven drug discovery platform into preclinical validation through a strategic collaboration with the Peter MacCallum Cancer Centre, while progressing its therapeutic pipeline and commercial leadership.

EMVision Medical Devices has secured ethics approvals for two pivotal clinical studies and received a $400,000 milestone payment, marking significant progress toward commercialising its portable First Responder brain scanner.

Powerhouse Ventures Limited reports its first operating cash profit within a year of restructuring, driven by three distinct business divisions and a strengthened balance sheet.

Freelancer Limited has reported its strongest half-year profit to date, driven by growth across its freelancing, escrow, and freight platforms, while setting ambitious targets for AI productisation and double-digit revenue growth in FY25.

Mach7 Technologies has updated its FY25 guidance, reporting positive cash flow and a solid financial position, while appointing Teri Thomas as its new CEO to steer the company’s next growth phase.

Nova Minerals has launched a 15,000-meter drilling campaign at its Estelle Project targeting gold and antimony, while advancing a US Department of Defense grant application to fast-track its antimony development.

BSA Limited reported a 7% increase in FY25 revenue to $286.8 million and a 42% rise in EBITDA pre-significant items, despite losing key contracts that accounted for 92% of its revenue. The company is undertaking significant restructuring to navigate these challenges.

Mach7 Technologies closes FY25 with solid recurring revenue growth, positive cash flow, and a refreshed leadership team focused on innovation and customer value.